Aimei Health Technology C... (AFJK)
NASDAQ: AFJK
· Real-Time Price · USD
11.17
0.00 (0.00%)
At close: Aug 14, 2025, 11:07 AM
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co. Ltd

Country | United States |
IPO Date | n/a |
Industry | Shell Companies |
Sector | Financial Services |
Employees | 2 |
CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street New York City, New York United States | |
Website | n/a |
Stock Details
Ticker Symbol | AFJK |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001979005 |
CUSIP Number | n/a |
ISIN Number | KYG013411098 |
Employer ID | 00-0000000 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Junheng Xie | Chief Executive Officer, Secretary & Director |
Heung Ming Wong | Chief Financial Officer & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 13, 2025 | 10-Q | Quarterly Report |
Aug 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 08, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 06, 2025 | 8-K | Current Report |
Jul 07, 2025 | 8-K | Current Report |
Jun 11, 2025 | 8-K | Current Report |
Jun 06, 2025 | 8-K | Current Report |
May 14, 2025 | 10-Q | Quarterly Report |
May 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
May 06, 2025 | 8-K | Current Report |